A randomised, placebo-controlled, single-blind study to characterise the biomarker effects of the CSF-1 receptor antagonist JNJ-40346527 in participants with mild cognitive impairment | C4C
We would like to perform a CRIS search to identify MHOA (Mental Health of Older Adults & Dementia) patients who may be eligible for the MICAD study which aims to trial a new medication that is designed to detect changes in biological markers associated with early AD, before it progresses to dementia. This is a multi-centre study, South London and Maudsley is one of the participating sites, collaborating with two other sites, University of Cambridge, and University of Oxford.